Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aptinyx Inc. | 8,891,758 | reported | 26 Oct 2020 | tx 1+3,333,333 |
| Dicerna Pharmaceuticals Inc | 7,330,237 | reported | 29 May 2019 | tx 1−1,600,000 |
| Xilio Therapeutics, Inc. | 2,805,413 | reported | 10 Dec 2021 | tx 4+42,469 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Dec 2021 | PURCHASE | Xilio Therapeutics, Inc. | 13,458 | 9.62 USD | first after silence |
| 10 Dec 2021 | PURCHASE | Xilio Therapeutics, Inc. | 3,188 | 10.24 USD | |
| 10 Dec 2021 | PURCHASE | Xilio Therapeutics, Inc. | 21,812 | 9.56 USD | |
| 09 Dec 2021 | PURCHASE | Xilio Therapeutics, Inc. | 4,011 | 9.84 USD | |
| 26 Oct 2020 | PURCHASE | Aptinyx Inc. | 3,333,333 | 3.00 USD | |
| 29 May 2019 | SALE | Dicerna Pharmaceuticals Inc | 1,600,000 | 12.50 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 Dec 2021.